New York, NY - January 6, 2025 - Sichenzia Ross Ference Carmel LLP announced that it represented AEON Biopharma, Inc. (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a …
Sichenzia Ross Ference Carmel LLP represents Alset Inc. in $1.5 Million Registered Direct Offering
Press Release – New York, NY – January 3, 2025 – Sichenzia Ross Ference Carmel LLP announced today that it represented Alset Inc. (NASDAQ: AEI), a diversified holding company principally engaged …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc.
New York, NY - October 9, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent for the $8.2 million private placement from …
Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资
新闻稿 – 纽约州纽约 – 2024 年 9 月 24 日 – Sichenzia Ross Ference Carmel LLP 今天宣布，它代表 Sharps Technology, Inc.（纳斯达克股票代码：STSS），这是一家创新型医疗器械和药品包装公司，提供一流的专利技术注射器产品，在其先前宣布的约 350 万美元的过桥融资结束时。 Aegis Capital …
Continue Reading about Sichenzia Ross Ference Carmel LLP 代表 Sharps Technology, Inc. 完成 350 万美元过桥融资 →
Sichenzia Ross Ference Carmel LLP Represents Sharps Technology, Inc. in Closing of $3.5 Million Bridge Financing
Press Release – New York, NY – September 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $81 Million Underwritten Public Offering for Farmmi, Inc.
Press Release – New York, NY – September 15, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering for …
